These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 33118291)

  • 1. Antidiabetic medication use in commercially insured children and adolescents in the United States from 2004 to 2019.
    Sun JW; Hernández-Díaz S; Bourgeois FT; Haneuse S; Brill G; Bateman BT; Huybrechts KF
    Diabetes Obes Metab; 2021 Feb; 23(2):444-454. PubMed ID: 33118291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of non-insulin diabetes medicines after insulin initiation: A retrospective cohort study.
    Xu Y; Pilla SJ; Alexander GC; Murimi IB
    PLoS One; 2019; 14(2):e0211820. PubMed ID: 30759121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-world treatment escalation from metformin monotherapy in youth-onset Type 2 diabetes mellitus: A retrospective cohort study.
    Vajravelu ME; Hitt TA; Amaral S; Levitt Katz LE; Lee JM; Kelly A
    Pediatr Diabetes; 2021 Sep; 22(6):861-871. PubMed ID: 33978986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment patterns, persistence and adherence rates in patients with type 2 diabetes mellitus in Japan: a claims-based cohort study.
    Nishimura R; Kato H; Kisanuki K; Oh A; Hiroi S; Onishi Y; Guelfucci F; Shimasaki Y
    BMJ Open; 2019 Mar; 9(3):e025806. PubMed ID: 30826768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A population-based analysis of antidiabetic medications in four Canadian provinces: Secular trends and prescribing patterns.
    Secrest MH; Azoulay L; Dahl M; Clemens KK; Durand M; Hu N; Targownik L; Turin TC; Dormuth CR; Filion KB
    Pharmacoepidemiol Drug Saf; 2020 Jan; 29 Suppl 1():86-92. PubMed ID: 31464069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. National Rates of Initiation and Intensification of Antidiabetic Therapy Among Patients With Commercial Insurance.
    Gilstrap LG; Mehrotra A; Bai B; Rose S; Blair RA; Chernew ME
    Diabetes Care; 2018 Aug; 41(8):1776-1782. PubMed ID: 29794151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Race and medication adherence in Medicaid enrollees with type-2 diabetes.
    Shenolikar RA; Balkrishnan R; Camacho FT; Whitmire JT; Anderson RT
    J Natl Med Assoc; 2006 Jul; 98(7):1071-7. PubMed ID: 16895275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of oral antidiabetic drugs in Japanese working-age patients with type 2 diabetes mellitus: dosing pattern for metformin initiators.
    Kameda T; Kumamaru H; Nishimura S; Kohsaka S; Miyata H
    Curr Med Res Opin; 2020 May; 36(5):749-756. PubMed ID: 32050809
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacologic treatment of type 2 diabetes: injectable medications.
    Tran L; Zielinski A; Roach AH; Jende JA; Householder AM; Cole EE; Atway SA; Amornyard M; Accursi ML; Shieh SW; Thompson EE
    Ann Pharmacother; 2015 Jun; 49(6):700-14. PubMed ID: 25802244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measuring adherence to oral antidiabetic multi-drug treatment: Comparative validity of prescription claims-based adherence measures against hospitalization.
    Zongo A; Grégoire JP; Moisan J; Guénette L
    Res Social Adm Pharm; 2019 Jun; 15(6):738-743. PubMed ID: 30253976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
    Krentz AJ; Bailey CJ
    Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progression to insulin for patients with diabetes mellitus on dual oral antidiabetic therapy using the US Department of Defense Database.
    Rascati K; Richards K; Lopez D; Cheng LI; Wilson J
    Diabetes Obes Metab; 2013 Oct; 15(10):901-5. PubMed ID: 23531154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative adherence to diabetes drugs: An analysis of electronic health records and claims data.
    Flory J; Gerhard T; Stempniewicz N; Keating S; Rowan CG
    Diabetes Obes Metab; 2017 Aug; 19(8):1184-1187. PubMed ID: 28266807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of antihypertensive, antidiabetic, and dyslipidemic prescription medication use among children and adolescents.
    Liberman JN; Berger JE; Lewis M
    Arch Pediatr Adolesc Med; 2009 Apr; 163(4):357-64. PubMed ID: 19349565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adherence to oral antidiabetic medications in the pediatric population with type 2 diabetes: a retrospective database analysis.
    Adeyemi AO; Rascati KL; Lawson KA; Strassels SA
    Clin Ther; 2012 Mar; 34(3):712-9. PubMed ID: 22381712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacologic treatment of type 2 diabetes: oral medications.
    Tran L; Zielinski A; Roach AH; Jende JA; Householder AM; Cole EE; Atway SA; Amornyard M; Accursi ML; Shieh SW; Thompson EE
    Ann Pharmacother; 2015 May; 49(5):540-56. PubMed ID: 25667196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adherence to oral antidiabetic therapy in a managed care organization: a comparison of monotherapy, combination therapy, and fixed-dose combination therapy.
    Melikian C; White TJ; Vanderplas A; Dezii CM; Chang E
    Clin Ther; 2002 Mar; 24(3):460-7. PubMed ID: 11952029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adherence to oral antidiabetic agents with pioglitazone and metformin: comparison of fixed-dose combination therapy with monotherapy and loose-dose combination therapy.
    Barner JC
    Clin Ther; 2011 Sep; 33(9):1281-8. PubMed ID: 21840054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of early medication treatment and metformin use for cancer prevention in diabetes patients: a nationwide sample cohort study in Korea using extended landmark time analysis.
    Seo HJ; Oh HS
    Epidemiol Health; 2021; 43():e2021103. PubMed ID: 34922421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.